Papillary thyroid microcarcinoma. Long-term outcome in 587 cases compared with published data;Il Microcarcinoma papillare della tiroide: Nostra esperienza e letteratura a confronto

Minerva Chirurgica

Volumn 62, Issue 5, 2007, Pages 315-325

  Pelizzo, M R ^a   Merante Boschin, I ^a   Tomato, A ^a   Piotto, A ^a   Bernante, P ^a   Pagetta, C ^a   Casal Ide, E ^a   Mazzarotto, R ^b   Casara, D ^b   Rubello, D ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

Prognosis; Thyroidectomy; Tyroideal neoplasms, Surgery

Indexed keywords

ARTICLE; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; PAPILLARY CARCINOMA; RETROSPECTIVE STUDY; RISK ASSESSMENT; THYROID TUMOR; THYROIDECTOMY; TREATMENT OUTCOME;

CARCINOMA, PAPILLARY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 36649037590     PISSN: 00264733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Hedinger C. Williams ED, Sobin LH. The WHO histological classification of thyroid tumours: a commentary on the second edition. Cancer 1989;69:908-11.
2. Bramley MD, Harrison BJ. Papillary microcarcinoma of the thyroid gland. Br J Surg 1996;83:159-64.
3. Pelizzo MR, Boschin IM, Toniato A, Piotto A, Bernante P, Pagetta C et al. Papillary thyroid microcarcinoma (PTMC): prognostic factors, management and outcome in 403 patients. Eur J Surg Oncol 2006;32:1144-8.
4. Frantz VK. Lateral aberrant thyroids. Ann Surg 1942;115:183-7.
5. Kasai N, Sakamoto A. New subgrouping of small thyroid carcinoma. Cancer 1987;60:1767-70.
6. Mazzaferri EL, Jhiang SM. Long term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418-28.
7. Harach HR, Franssila KO, Wasenius V. Occult papillary carcinoma of the thyroid; a normal finding in Finland. A systemic autopsy study. Cancer 1985;56:531-8.
8. Miki H, Oshimo K, Inoue H, Kawano M, Tanaka K, Komaki K, et al. Diagnosis and surgical treatment of small papillary carcinomas of the thyroid gland. J Surg Oncol 1993:54:78-81.
9. Vichery AL Wang CA, Walker AM. Treatment of intrathyroidal papillary carcinoma of the thyroid . Cancer 1987;60:2587-95.
10. Pelizzo MR, Boschin IM, Toniato A, Pagetta C, Piotto A, Bernante P et al. Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a monoinstitutional 12-year experience. Nucl Med Commun 2004;25:547-52.
11. Black BM. Papillary adenocarcinoma of the thyroid gland, so called lateral aberrant thyroid. World J Surg 1948;56:134-44.
12. Wozencraft P, Foote FW, Frazell EL. Occult carcinomas of the thyroid: their bearing on the concept of lateral aberrant thyroid cancer. Cancer 2003;1:574-83.
13. Bondeson L, Ljungberg O. Occult thyroid carcinoma at authopsy in Malmo, Sweden. Cancer 1981;47:319-23.
14. Lang W, Borrusch H, Bauer L. Occult carcinomas of the thyroid. Evaluation of 1020 sequential autopsies. Am J Clin Pathol 1988;90:72-6.
15. Bisi H, Fernandes VS, de Camargo RY, Koch L, Abdo AH, de Brito T. The prevalence of unsuspected thyroid pathology in 300 sequential autopsies with special reference to the incidental carcinoma. Cancer 1989;64:1888-93.
16. Yamamoto Y, Maeda T, Izumi K, Otsuka H. Occult papillary carcinoma of the thyroid. A study of 408 autopsy cases. Cancer 1990;65:1173-9.
17. Pelizzo MR, Bernante P, Toniato A, Fassina A. Frequency of thyroid carcinoma in a recent series of 539 consecutive thyroidectomies for multinodular goiter. Tumori 1997;83:653-5.
18. Fukunaga FH, Yatani R. Geographic pathology f occult thyroid carcinoma. Cancer 1975;36:1095-9.
19. Ito Y, Uruno T, Nakano K, Takamura Y, Miya A, Kobayashi K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 2003;13:381-7.
20. Farkas EA, King TA, Bolton JS, Fuhrman GM. A comparison of total thyroidectomy and lobectomy I the treatment of dominant thyroid nodules. Am Surg 2002;68:678-82.
21. Pearce EN, Braverman LE. Papillary thyroid microcarcinoma outcomes and implications for treatment. J Clin Endocrinol Metab 2004;89:3710-2.
22. Rassael H, Thompson LD, Heffes CS. A rationale for conservative management of microscopic papillary carcinoma of the thyroid gland: a clinicopathologic correlation of 90 cases. Eur Arch Otorhinolaryngol 1998;255:462-7.
23. De Groot LJ, Kaplan EL, Mc Cormick M, Straus FH. Natural history, treatment and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990;71:414-24.
24. Cohn KH, Backdahl M, Forsslund G, Auer G, Zetterberg A, Lundell G et al. Biologic considerations and operative strategy in papillary thyroid carcinoma: arguments against the routine performance of total thyroidectomy. Surgery 1984;96:957-71.
25. Hay ID, Grant CS, Van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ et al. Papillary thyroid microcarcinoma. A study of 535 cases observed in a 50-year period. Surgery 1992;112:1139-42.
26. Rodriguez JM, Moreno A, Parrilla P, Sola J, Soria T, Tebar FJ et al. Papillary thyroid microcarcinoma: clinical study and prognosis. Eur J Surg 1997;163:255-9.
27. Hubert JP, Kiernan PD, Bears OH, McConahey WM, Woolner LB. Occult papillary carcinoma of the thyroid. Arch Surg 1980;115:394-8.
28. Baudin E, Travagli JP, Ropers J, Mancusi F, Bruno-Bossio G, Caillou B et al. Microcarcinoma of the thyroid gland. The Gustave Roussy Institute experience. Cancer 1998;83:553-9.
29. Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH. Papillary microcarcinoma of the thyroid- prognostic significance of lymph node metastasis and multifocality. Cancer 2003;98:31-40.
30. Kupferman ME, Mandel SJ, DiDonato L, Wolf P, Webwr RSI. Safety of completion thyroidectomy following unilateral lobectomy for well differentiated thyroid cancer. Laringoscope 2002;112:1209-12.
31. Salvadori B, Del Bo R, Pilotti S, Grassi M, Cusumano F. Occult papillary carcinoma of the thyroid: a questionable entity. Eur J Cancer A 1993;29:1817-20.
32. Falvo L, D'Ercole C, Sorrenti S, D'Andrea V, Catania A, Berni A et al. Papillary microcarcinoma of the thyroid gland: analysis of prognostic factors including histological subtype. Eur J Surg 2002 (Suppl 588):28-32.
33. Sugitani I, Fujimoto Y. Symptomatic versus asymptomatic papillary thyroid microcarcinoma: a retrospective analysis of surgical outcome and prognostic factors. Endocr J 1999;46:209-16.
34. Nagouchi S, Yamashita M, Murakami N, Nakayama I, Toda M, Kawamoto H. Small carcinomas of the thyroid. A long term follow up of 876 patients. Arch Surg 1996;13:187-91.
35. Shaha AR. Mangement of the neck in thyroid cancer. Otolaryngol Clin North Am 1998;31:823-31.
36. Mazzaferri EL, Young RL. Papillary thyroid carcinoma: a 10 year follow up report of the impact of therapy in 576 patients. Am J Med 1981;70:511-8.
37. Sakorafas GH, Giotakis J, Stafyla V. Papillary thyroid microcarcinoma: a surgical perspective. Cancer Treat Rev 2005;31:423-38.
38. Appetecchia M, Scarcello G Pucci E, Procaccini A. Outcome after treatment of papillary thyroid carcinoma. J Exp Clin Cancer Res 2002;21:159-64.
39. Rossi RL, Cady B, Silverman ML, Wool MS, Horner TA. Current results of conservative surgery for differentiated thyroid carcinoma. World J Surg 1986;10:612-22.
40. Nasir A, Chaudhry AZ, Gillespie J, Kaiser HE. Papillary microcarcinoma of the thyroid: a clinico-pathologic and prognostic review. In Vivo 2000;14:367-76.
41. Strate SM, Lee EL, Childers JH. Occult papillary carcinoma of the thyroid. Cancer 1984;54:1093-100.
42. Cady B. Primary carcinoma of the thyroid Sem Surg Oncol 1991;7:81-6.
43. Ceccarelli C, Pacini F, Lippi F, Elisei R, Arganini M, Miccoli P et al. Thyroid cancer in children and adolescents. Surgery 1988;104:1143-8.
44. Pellegritti G, Scollo C, Lumera G, Regalbuto C, Vigneri R, Belfiore A. Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. J Clin Endocrinol Metab 2004;89: 3713-20.
45. Satge D, Grob JC, Pusel J, Methlin G. Microcarcinoma thyroidienne d'evolution fatale. Arch Anat Cytol Pathol 1990;38:143-51.
46. Lin KD, Lin JD, Huang MJ, Huang HS, Jeng LB, Chao TC et al. Clinical presentations and predictive variable of thyroid microcarcinoma with distant metastases. Int Surg 1997;82:378-81.
47. Thyroid task Force. AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. Endocrine Pract 2001;7:202-20.
48. Sugitani I, Yanagysawa A, Shimizu A, Kato M, Fujimoto Y. Clinicopathologic and immunohistochemical studies of papillary thyroid microcarcinoma presenting with cervical lymphoadenopathy. World J Surg 1998;22:731-7.
49. Fujimoto Y, Obara T, Ito Y, Kodama T, Aiba M, Yamaguchi K. Diffuse sclerosing variant of of papillary carcinoma of the thyroid . Clinical importance, surgical treatment, and follow up study. Cancer 1990;66:2306-10.
50. Brown DC, Gatter KC. Monoclonal antibody ki-67; its use in histopathology. Histopathology 1990;17:489.
51. Soda G, Antonaci A, Bosco D, Nardoni S, Melis M. Expression of bcl-2, c-erbB-2, P53, and p21 (wafl-cip1) protein in thyroid carcinomas. J Exp Clin Cancer Res 1999;18:363-7.
52. Delellis RA. Pathology and genetics of thyroid carcinoma. J Surg Oncol 2006;94:662-9.
53. Stocker DJ, Burch HB. Thyroid cancer yeld in patients with grave's disease. Minerva Endocrinol 2003;28:205-12.
54. Cappelli C, Castellano M, Braga M, Gandrossi E, Pirola I, De Martino E et al. Aggressiveness and outcome of papillary thyroid carcinoma (PTC) versus microcarcinoma (PMC): a monoinstitutional experience. J Surg Oncol 2007;95:555-60.
55. Voutilainen PE, Siironen P, Franssila KO, Sivula A, Haapiainen RK, Haglund CH. AMES, MACIS, and TNM prognostic classifications in papillary thyroid carcinoma. Anticancer Res 2003;23:4283-8.
56. D'Avanzo A, Ituarte P, Treseler P, Kebebew E, Wu J, Wong M et al. Prognostic scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome. Thyroid 2004;14:453-8.